TITLE

Effects of diclofenac on EPC liposome membrane properties

AUTHOR(S)
Ferreira, Helena; Lúcio, Marlene; Lima, José L. F. C.; Matos, Carla; Reis, Salette
PUB. DATE
July 2005
SOURCE
Analytical & Bioanalytical Chemistry;Jul2005, Vol. 382 Issue 5, p1256
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In this work the interaction of a non-steroidal anti-inflammatory drug (NSAID), diclofenac, with egg yolk phosphatidylcoline (EPC) liposomes, used as cell-membrane models, was quantified by determination of the partition coefficient. The liposome/aqueous phase partition coefficient was determined by derivative spectrophotometry, fluorescence quenching, and measurement of zeta-potential. Theoretical models based on simple partition of the diclofenac between two different media, were used to fit the experimental data, enabling the determination of Kp. The three techniques used yielded similar results. The effects of the interaction on the membrane’s characteristics were further evaluated, either by studying membrane potential changes or by effects on membrane fluidity. The liposome membrane potential and the size and size-homogeneity of liposomes were measured by light scattering. The effects of diclofenac on the internal viscosity or fluidity of the membrane were determined by use of spectroscopic probes—a series of n-(9-anthroyloxy) fatty acids in which the carboxyl terminal group is located at the interfacial region of the membrane and the fluorescent anthracene group is attached at different positions along the fatty acid chain. The location of the diclofenac on the membrane was also evaluated, by fluorescence quenching using the same series of fluorescent probes. Because the fluorescent anthracene group is attached at different positions along the fatty acid chain, it is possible to label at a graded series of depths in the bilayer. The interactions between the drug and the probe are a means of predicting the location of the drug on the membrane.
ACCESSION #
17551468

 

Related Articles

  • Design And Characterization Of Diclofenac Potassium Tablet For Colon Targeting. Anil kumar J. Shinde; Vinod S. Ingole; Gajanan M. Misale; Harinath N. More // International Journal of PharmTech Research;Apr-Jun2013, Vol. 5 Issue 2, p645 

    The present study was to formulate tablet of Diclofenac potassium using the hydrophilic polymer hydroxy propyl methyl cellulose (HPMC), Hydroxypropyl Cellulose (HPC), Ethyl Cellulose(N22), Cross Povidone and Sodium Starch Glycolate as a superdisintegrants and Instacoat EN super II as a enteric...

  • Upper limb gangrene following intramuscular diclofenac: a rare side effect. Hajong, Ranendra // Journal of Surgical Case Reports;Feb2013, Vol. 2013 Issue 2, p1 

    Diclofenac is a very commonly used analgesic medication. Diclofenac is a non-steroidal antiinflammatory drug and acts by inhibiting COX (cyclo-oxygenase) 1 and 2. It has both analgesic and anti-pyretic effects. It can be administered both orally and parentarelly. Among the many side effects of...

  • Evaluation of Olibanum and its Resin as Rate Controlling Matrix for Controlled Release of Diclofenac. Chowdary, K. P. R.; Mohapatra, P.; Murali Krishna, M. N. // Indian Journal of Pharmaceutical Sciences;2006, Vol. 68 Issue 4, p497 

    Olibanum and its resin and carbohydrate fractions were evaluated as rate controlling matrix materials in tablets for controlled release of diclofenac. Diclofenac matrix tablets were formulated employing olibanum and its resin and carbohydrate fractions in different concentrations and the tablets...

  • Comparative Study on The Effect of Paracetamol, Diclofenac and their Combination in Post Operative Pain Relief of Cesarean Section. Taneja, Ashima; Vidhushi; Kaur, Tanudeep; Sood, Indu Veena // JK Science;Jan-Mar2015, Vol. 17 Issue 1, p30 

    To evaluate whether the post operative pain can be managed by a single agent or a combination. A prospective non randomised study of 150 patients undergoing caesarean section over 5 months were divided into three groups. Group I received paracetmol 1g i.v 6hourly, group II received Diclofenac...

  • Ulcerogenita kortikoidu - pre��vaj�c� m�tus mezi cesk�mi l�kari. Hlavov�, K.; Mart�nek, J.; Z�vada, F.; Zavoral, M.; Urban, O.; Rejchrt, S. // General Practitioner / Prakticky Lekar;Dec2011, Vol. 91 Issue 12, p710 

    Corticosteroids were once considered highly ulcerogenic drugs. Despite the fact that many studies have not confirmed this fact, a large percentage of doctors still consider them as ulcerogenic. Even the renowned textbooks from various disciplines do not consider corticosteroids ulcerogenic...

  • Synthesis and Pharmacological Activity of Betulin, Betulinic Acid, and Allobetulin Esters. Flekhter, O.; Medvedeva, N.; Karachurina, L.; Baltina, L.; Galin, F.; Zarudii, F.; Tolstikov, G. // Pharmaceutical Chemistry Journal;Aug2005, Vol. 39 Issue 8, p401 

    A series of new triterpene hemisuccinates, hemiphthalates and nicotinates have been obtained with 52 – 95% yields via reactions of monoacetates of betulin, betulinic acid, and allobetulin with succinic and phthalic anhydrides and with nicotinic acid chloroanhydride....

  • Development and Evaluation of Sustained Delivery of Diclofenac Sodium from Hydrophilic Polymeric Beads. Dhanaraju, M. D.; Sundar, V. D.; NandhaKumar, S.; Bhaskar, K. // Journal of Young Pharmacists;2009, Vol. 1 Issue 4, p301 

    Sustained-release polymeric beads containing diclofenac sodium were fabricated with hydrophilic polymers, sodium carboxymethyl cellulose (Na CMC), and sodium alginate (Na alginate). Particulate beads of Na CMC and Na alginate were prepared by the ionotropic gelation method using calcium chloride...

  • Diclofenac gel provides modest pain relief for people with osteoarthritis in one knee.  // BMJ: British Medical Journal (International Edition);2/11/2006, Vol. 332 Issue 7537, p313 

    The article summarises a study which found that diclofenac gel provides pain relief for people with osteoarthritis in one knee. Supported by drug manufacturer Novartis, the authors evaluated the topical gel in a clinical trial with modern robust methods. Patients using the gel reported a...

  • Design and characterization of Diclofenac sodium tablets containing Mangifera indica resin as release retardant. Shingala, Vipul Kumar; Singh, Anoop Kumar; Yadav51, Sudhir Kumar; Sivakumar, T. // International Journal of PharmTech Research;Jul-Sep2010, Vol. 2 Issue 3, p2107 

    The aim of the present study is to investigate the resin of mangifera indica (mango) as a tablet retardant polymer in the formulation development of sustained release of drugs, employing diclofenac sodium as a model drug. The resin was isolated from mangifera indica plant exudates. Various...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics